Clinical Trial: A Study of Updated mRNA Seasonal Influenza Vaccines

U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07884175) titled 'A Study of Updated mRNA Seasonal Influenza Vaccines' on Oct. 13.

Brief Summary: The purpose of this study is to evaluate the immunogenicity and safety of updated strain-containing compositions of the mRNA-1010 vaccines within the current epidemiological environment.

Study Start Date: Oct. 15

Study Type: INTERVENTIONAL

Condition: Seasonal Influenza

Intervention: BIOLOGICAL: mRNA-1010

Sterile liquid for injection

BIOLOGICAL: Licensed High-Dose Seasonal Influenza Vaccine

Sterile liquid for injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: ModernaTX, Inc.

Disclaimer: Curated by HT Syndication....